---
title: "Understanding the Market | XTALPI rose over 4% recently after being included in the FTSE China Small Cap Index, with its AI pharmaceutical commercialization capabilities being validated"
description: "XTALPI rose over 4%, as of the time of writing, up 4.56%, reported at HKD 11.92, with a turnover of HKD 2.259 billion. In terms of news, recently, FTSE Russell updated the semi-annual adjustment list "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/258471980.md"
published_at: "2025-09-23T07:38:03.000Z"
---

# Understanding the Market | XTALPI rose over 4% recently after being included in the FTSE China Small Cap Index, with its AI pharmaceutical commercialization capabilities being validated

> XTALPI rose over 4%, as of the time of writing, up 4.56%, reported at HKD 11.92, with a turnover of HKD 2.259 billion. In terms of news, recently, FTSE Russell updated the semi-annual adjustment list for the FTSE Global Equity Index Series for September. Among them, XTALPI was included in the FTSE China Small Cap Index. The related adjustments officially took effect after the market closed on September 19. Analysts pointed out that inclusion in an international index means broader capital attention and liquidity premium. CITIC Securities' research report indicated that XTALPI achieved profitability for the first time, securing nearly USD 6 billion in orders, further validating its AI pharmaceutical commercialization capabilities. In the first half of this year, benefiting from cooperation with DoveTree, the company achieved revenue of RMB 517 million, a year-on-year increase of 403.8%; adjusted net profit was RMB 141.6 million, achieving half-year profitability for the first time, and made positive progress in embodied intelligence (smart spoon) and Multi-Agent aspects

According to Zhitong Finance APP, XTALPI (02228) rose over 4%, up 4.56% as of the time of writing, priced at HKD 11.92, with a transaction volume of HKD 2.259 billion.

In terms of news, recently, FTSE Russell updated the semi-annual adjustment list for the FTSE Global Equity Index Series for September. XTALPI was included in the FTSE China Small Cap Index. The related adjustments officially took effect after the market closed on September 19. Analysts pointed out that inclusion in an international index means broader capital attention and liquidity premium. CITIC Securities research report indicated that XTALPI achieved profitability for the first time, securing nearly USD 6 billion in large orders, further validating its AI pharmaceutical commercialization capabilities. In the first half of this year, benefiting from the cooperation with DoveTree, the company achieved revenue of RMB 517 million, a year-on-year increase of 403.8%; the adjusted net profit was RMB 141.6 million, achieving half-year profitability for the first time, and making positive progress in embodied intelligence (smart spoon) and Multi-Agent areas

### Related Stocks

- [02228.HK - XTALPI](https://longbridge.com/en/quote/02228.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 中信建投：AI 漫剧产业链投资机遇 | 中信建投证券发布研究报告，指出 AI 漫剧产业链面临投资机遇。预计到 2026 年，AI 短剧市场将持续高增长，爆款数量显著增加。AI 漫剧制作公司作为视频大模型的主要客户，受大模型替代风险较小。报告强调，AI 漫剧行业将迎来战略机遇，市场 | [Link](https://longbridge.com/en/news/276421887.md) |
| 重磅合作！晶泰控股携手维升药业 AI 赋能内分泌新药研发 | 2 月 5 日，两家港股公司晶泰控股与维升药业共同宣布达成项目协议及长期战略合作，本次合作整体规模达数千万元，围绕研发阶段目标... | [Link](https://longbridge.com/en/news/275049353.md) |
| 马年第一涨，AI 股杀疯了 | 马年第一涨，AI 股杀疯了 | [Link](https://longbridge.com/en/news/276525078.md) |
| 中国 AI 破亿潮来了，最难的题留给了社交 | 春节期间，中国的 AI 市场迎来了新的发展趋势，重点转向社交领域。阿里、腾讯和字节跳动等公司纷纷将 AI 融入用户日常生活，目标是占领用户的时间和习惯。社交被视为 AI To C 化的关键战场，但也是最具挑战性的领域。与此同时，硅谷的 AI | [Link](https://longbridge.com/en/news/276524943.md) |
| AI 难过老人关 | 春节期间，AI 技术在各大活动中广泛应用，字节、千问和腾讯等公司纷纷发布战报，显示出 AI 互动和订单的激增。然而，尽管技术发展迅速，老年用户在使用 AI 产品时仍面临困难，尤其是在操作界面和输入方式上。文章通过小鱼的亲身经历，反映了老年人 | [Link](https://longbridge.com/en/news/276504820.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.